| Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder |
17 |
| Atypical Antipsychotics for Irritability in Pediatric Autism: A Systematic Review and Network Meta-Analysis |
11 |
| Probiotics for Gastrointestinal Symptoms and Quality of Life in Autism: A Placebo-Controlled Pilot Trial |
10 |
| National Patterns of Commonly Prescribed Psychotropic Medications to Young People |
9 |
| Risk Factors for Drug Overdose in Young People: A Systematic Review of the Literature |
9 |
| CYP2C19-Guided Escitalopram and Sertraline Dosing in Pediatric Patients: A Pharmacokinetic Modeling Study |
9 |
| A Focused Review on the Treatment of Pediatric Patients with Atypical Antipsychotics |
8 |
| Reduced Reward Responsiveness Predicts Change in Depressive Symptoms in Anxious Children and Adolescents Following Treatment |
8 |
| Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study |
7 |
| Pharmacogenetics of Sertraline Tolerability and Response in Pediatric Anxiety and Depressive Disorders |
7 |
| Antipsychotics in Dutch Youth: Prevalence, Dosages, and Duration of Use from 2005 to 2015 |
7 |
| Relationship Between Symptomatic and Functional Improvement and Remission in a Treatment Response to Stimulant Trial |
6 |
| Characteristics of Children Prescribed Antipsychotics: Analysis of Routinely Collected Data |
6 |
| New Formulations of Stimulants: An Update for Clinicians |
6 |
| Pharmacological Treatment of Youth Substance Use Disorders |
6 |
| Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder |
6 |
| Medication Adherence Among Children and Adolescents with Severe Mental Illness: A Systematic Review and Meta-Analysis |
5 |
| Inflammatory Cytokines in Children and Adolescents with Depressive Disorders: A Systematic Review and Meta-analysis |
5 |
| Update on Randomized Placebo-Controlled Trials in the Past Decade for Treatment of Major Depressive Disorder in Child and Adolescent Patients: A Systematic Review |
5 |
| Predictors and Moderators of Antipsychotic-Related Weight Gain in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study |
5 |
| Psychometric Properties of the Patient Health Questionnaire-9 Modified for Major Depressive Disorder in Adolescents |
5 |
| Prospective, Open Trial of Adjunctive Triple Chronotherapy for the Acute Treatment of Depression in Adolescent Inpatients |
5 |
| PANDAS and PANS: Clinical, Neuropsychological, and Biological Characterization of a Monocentric Series of Patients and Proposal for a Diagnostic Protocol |
5 |
| How Informative Are Self-Reported Adult Attention-Deficit/Hyperactivity Disorder Symptoms? An Examination of the Agreement Between the Adult Attention-Deficit/Hyperactivity Disorder Self-Report Scale V1.1 and Adult Attention-Deficit/Hyperactivity Disorder Investigator Symptom Rating Scale |
5 |
| Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial |
5 |
| Pharmacokinetics of HLD a Delayed-Release and Extended-Release Methylphenidate: Evaluation of Dose Proportionality, Food Effect, Multiple-Dose Modeling, and Comparative Bioavailability with Immediate-Release Methylphenidate in Healthy Adults |
4 |
| The Correlation Between the Severity of Premonitory Urges and Tic Symptoms: A Meta-Analysis |
4 |
| Piloting of COPES: An Empirically Informed Psychosocial Intervention on an Adolescent Psychiatric Inpatient Unit |
4 |
| Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study |
4 |
| Establishing a Pediatric Acute-Onset Neuropsychiatric Syndrome Clinic: Baseline Clinical Features of the Pediatric Acute-Onset Neuropsychiatric Syndrome Cohort at Karolinska Institutet |
4 |
| Psychostimulants: Influence on Body Mass Index and Height in a Pediatric Population with Attention-Deficit/Hyperactivity Disorder? |
4 |
| A Review of Factors Influencing the Three Phases of Medication Adherence in People with Attention-Deficit/Hyperactivity Disorder |
4 |
| No Differences in Weight Gain Between Risperidone and Aripiprazole in Children and Adolescents After 12 Months |
4 |
| Threat Responsiveness as a Function of Cannabis and Alcohol Use Disorder Severity |
4 |
| Psychometric Properties and Factor Structures of the Korean Version of Children's Depression Rating Scale-Revised |
4 |
| Developmental Consequences of Prenatal Substance Use in Children and Adolescents |
4 |
| Rating of the Effectiveness of 26 Psychiatric and Seizure Medications for Autism Spectrum Disorder: Results of a National Survey |
4 |
| Pharmacoepidemiology of Tourette and Chronic Tic Disorders in Sweden 2005-2013 |
4 |
| Second-Generation Antipsychotics in Adolescent Psychiatric Patients: Metabolic Effects and Impact of an Early Weight Change to Predict Longer Term Weight Gain |
4 |
| Stimulants Do Not Increase the Risk of Seizure-Related Hospitalizations in Children with Epilepsy |
4 |
| N-Acetylcysteine for Nonsuicidal Self-Injurious Behavior in Adolescents: An Open-Label Pilot Study |
4 |
| Simvastatin as an Adjunctive Therapy to Risperidone in Treatment of Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial |
4 |
| Use and Characteristics of Antipsychotic/Methylphenidate Combination Therapy in Children and Adolescents with a Diagnosis of Attention-Deficit/Hyperactivity Disorder |
4 |
| Steroid-Induced Psychosis in the Pediatric Population: A New Case and Review of the Literature |
4 |
| Does Acute Propranolol Treatment Prevent Posttraumatic Stress Disorder, Anxiety, and Depression in Children with Burns? |
4 |
| Quality of Life in Children and Youth with Obsessive-Compulsive Disorder |
3 |
| Long-Acting Injectable Atypical Antipsychotic Use in Adolescents: An Observational Study |
3 |
| Single-Dose Pharmacokinetics of HLD a Delayed-Release and Extended-Release Methylphenidate Formulation, in Healthy Adults and in Adolescents and Children with Attention-Deficit/Hyperactivity Disorder |
3 |
| Resting-State Quantitative Electroencephalography Demonstrates Differential Connectivity in Adolescents with Major Depressive Disorder |
3 |
| l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial |
3 |
